StockNews.com Initiates Coverage on Senseonics (NYSE:SENS)

Analysts at StockNews.com initiated coverage on shares of Senseonics (NYSE:SENS) in a report released on Monday. The brokerage set a “sell” rating on the stock.

Senseonics Stock Performance

Senseonics stock opened at $0.39 on Monday. The business’s 50-day simple moving average is $0.42 and its 200 day simple moving average is $0.49. The company has a current ratio of 3.96, a quick ratio of 3.70 and a debt-to-equity ratio of 1.79. Senseonics has a 12-month low of $0.37 and a 12-month high of $0.75.

Senseonics (NYSE:SENS) last released its earnings results on Thursday, August 8th. The company reported ($0.03) EPS for the quarter, hitting analysts’ consensus estimates of ($0.03). The firm had revenue of $4.87 million during the quarter, compared to analyst estimates of $4.86 million. Senseonics had a negative net margin of 335.15% and a negative return on equity of 225.98%. On average, equities analysts predict that Senseonics will post -0.12 EPS for the current fiscal year.

Institutional Trading of Senseonics

A number of institutional investors have recently modified their holdings of the company. Virtu Financial LLC bought a new stake in shares of Senseonics during the 1st quarter worth approximately $162,000. Price T Rowe Associates Inc. MD raised its stake in Senseonics by 16.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock valued at $196,000 after acquiring an additional 51,000 shares during the period. Vanguard Group Inc. raised its position in shares of Senseonics by 0.7% in the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after purchasing an additional 155,715 shares during the period. State Board of Administration of Florida Retirement System bought a new stake in shares of Senseonics during the 1st quarter worth about $91,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Senseonics by 30.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock valued at $483,000 after acquiring an additional 211,128 shares during the period. 12.36% of the stock is currently owned by institutional investors.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.